Tiny implants signal new way to treat cancer tumors

March 14, 2013, University of Edinburgh

Cancer patients could be treated more effectively in future with tiny, sensory implants that will monitor tumours in real time and in great detail.

The devices, about the size of an eyelash, would be implanted into patients' tumours. They would allow doctors to target radiotherapy, and ultimately chemotherapy, where and when it is most needed, improving patients' chances of recovery.

The devices will be designed to measure directly vital factors about tumours, such as their levels of and key , transmitting the information wirelessly to medical staff. These readings would enable doctors to identify and target areas of a tumour that are found to be resistant to radiotherapy and drug treatment.

Sensors would also take measurements to indicate how effective the treatment is in killing , enabling therapy to be personalised to an individual patient's cancer. Doctors would be able to monitor patients' progress with an unprecedented level of detail.

A team led by the University of Edinburgh, in collaboration with Heriot-Watt University, will develop the miniature chips in a five-year project to prove the technology, which they hope to follow with clinical trials.

The team also hopes eventually to develop chips that are capable of delivering doses of chemotherapy directly to a .

The £5.2 million project, Implantable Microsystems for Personalised Anti- (IMPACT), is funded by the Engineering and Physical Sciences Research Council.

Professor Alan Murray of the University of Edinburgh, who is leading the study, said: "Experts including scientists, engineers, clinicians and social scientists will be working to target cancer, one of the biggest health concerns of today, in an entirely new way. Our aim is, in the long term, help to alleviate suffering and to improve the outlook for very many ."

Explore further: Some breast cancer tumors may be resistant to a common chemotherapy treatment

Related Stories

Some breast cancer tumors may be resistant to a common chemotherapy treatment

March 27, 2012
Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.

Scientists reveal best imaging technique for ovarian cancer

February 15, 2012
Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ...

Bone cancer, from the lab to the clinic

June 8, 2011
A new study into osteosarcoma - cancer of the bone - will use advances in genomic research and analysis to identify new genes that give rise to the condition and to create personalised blood tests for children and young adults ...

Researchers develop non-invasive technique for predicting patients' response to chemotherapy

November 7, 2012
Researchers have developed a non-invasive way of predicting how much of a cancer-killing drug is absorbed by a tumour. The preliminary study, which will be reported at the 24th EORTC-NCI-AACR Symposium on Molecular Targets ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.